FDA Import Refusal AEK-5098759-1/11/1 — Novartis Healthcare
The FDA refused shipment AEK-5098759-1/11/1 from Novartis Healthcare (India) on May 22, 2024. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 22, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCC26 METFORMIN (ANTI-DIABETIC)
- Charges
- 75